461 related articles for article (PubMed ID: 28285551)
1. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG.
Haggag Y; Abdel-Wahab Y; Ojo O; Osman M; El-Gizawy S; El-Tanani M; Faheem A; McCarron P
Int J Pharm; 2016 Feb; 499(1-2):236-246. PubMed ID: 26746800
[TBL] [Abstract][Full Text] [Related]
3. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
4. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
S S; S M; P S L S; S S; S B; V P
Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
6. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
7. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
[TBL] [Abstract][Full Text] [Related]
8. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
Park W; Kim D; Kang HC; Bae YH; Na K
Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184
[TBL] [Abstract][Full Text] [Related]
9. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
Jain S; Rathi VV; Jain AK; Das M; Godugu C
Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
[TBL] [Abstract][Full Text] [Related]
12. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
13. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.
Liu J; Zhang SM; Chen PP; Cheng L; Zhou W; Tang WX; Chen ZW; Ke CM
J Mater Sci Mater Med; 2007 Nov; 18(11):2205-10. PubMed ID: 17668296
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
16. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles].
Pan Y; Xu H; Zhao HY; Wei G; Zheng JM
Yao Xue Xue Bao; 2002 May; 37(5):374-7. PubMed ID: 12579845
[TBL] [Abstract][Full Text] [Related]
17. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
18. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].
Pan Y; Li YJ; Gao P; Ding PT; Xu H; Zheng JM
Yao Xue Xue Bao; 2003 Jun; 38(6):467-70. PubMed ID: 14513811
[TBL] [Abstract][Full Text] [Related]
19. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
[TBL] [Abstract][Full Text] [Related]
20. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]